Intravenous (IV) glutathione is limited by an extremely short half-life in the plasma, and it cannot cross cell membranes intact, but must be broken down and resynthesized within the cell
13 KCs release pro-inflammatory cytokines, including tumor necrosis factor- (TNF-), interleukin (IL)-1, and IL-6, which recruit monocytes and drive macrophage polarization
This treatment requires no downtime and is an effective option for chronic bursitis and overuse-related inflammation
Treg cells are the peacekeepers of the immune system, responsible for telling other immune cells to stand down and not attack the bodys own tissues
Future studies may lead to breakthrough treatments for age-related conditions
Your journey begins with a focused consultation with our medical team